ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $222,525,000 | +36.2% | 1,292,998 | -0.7% | 0.50% | +34.8% |
| Q2 2021 | $163,422,000 | +5.9% | 1,302,275 | +14.4% | 0.37% | -1.8% |
| Q1 2021 | $154,365,000 | +15.1% | 1,138,303 | +8.6% | 0.38% | +14.8% |
| Q4 2020 | $134,087,000 | +34.6% | 1,048,043 | +18.4% | 0.33% | +8.5% |
| Q3 2020 | $99,643,000 | +149.6% | 885,475 | +111.3% | 0.31% | +112.5% |
| Q2 2020 | $39,926,000 | +45.3% | 419,078 | +37.1% | 0.14% | +6.7% |
| Q1 2020 | $27,477,000 | +61.6% | 305,743 | -4.6% | 0.14% | +107.7% |
| Q4 2019 | $16,998,000 | +46.9% | 320,600 | +9.5% | 0.06% | +35.4% |
| Q3 2019 | $11,570,000 | +39.9% | 292,834 | +45.4% | 0.05% | +45.5% |
| Q2 2019 | $8,273,000 | +47.2% | 201,384 | +66.9% | 0.03% | +37.5% |
| Q1 2019 | $5,620,000 | +83.7% | 120,677 | +71.8% | 0.02% | +60.0% |
| Q4 2018 | $3,059,000 | -22.9% | 70,231 | +1.3% | 0.02% | -6.2% |
| Q3 2018 | $3,966,000 | +22.2% | 69,303 | +3.6% | 0.02% | +14.3% |
| Q2 2018 | $3,245,000 | +46.1% | 66,878 | +17.7% | 0.01% | +40.0% |
| Q1 2018 | $2,221,000 | -2.9% | 56,815 | +5.4% | 0.01% | -9.1% |
| Q4 2017 | $2,287,000 | +35.6% | 53,880 | +19.3% | 0.01% | +37.5% |
| Q3 2017 | $1,686,000 | +23.2% | 45,180 | +0.3% | 0.01% | +14.3% |
| Q2 2017 | $1,369,000 | – | 45,038 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |